Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.849
-0.014 (-1.59%)
At close: Apr 28, 2026, 4:00 PM EDT
0.898
+0.049 (5.72%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Vivos Therapeutics Employees
Vivos Therapeutics had 109 employees as of December 31, 2024. The number of employees decreased by 14 or -11.38% compared to the previous year.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$66,576
Profits / Employee
-$80,802
Market Cap
11.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Co-Diagnostics | 115 |
| IRIDEX | 93 |
| VolitionRx | 75 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
VVOS News
- 13 days ago - Vivos Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 13 days ago - Vivos Therapeutics Reports Full Year 2025 Financial Results - GlobeNewsWire
- 13 days ago - Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - GlobeNewsWire
- 21 days ago - Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners - GlobeNewsWire
- 4 weeks ago - Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - GlobeNewsWire
- 6 weeks ago - Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy - GlobeNewsWire
- 2 months ago - Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies - GlobeNewsWire
- 3 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga